CA1327019C - Solution for washing and storing separated organs - Google Patents
Solution for washing and storing separated organsInfo
- Publication number
- CA1327019C CA1327019C CA000580728A CA580728A CA1327019C CA 1327019 C CA1327019 C CA 1327019C CA 000580728 A CA000580728 A CA 000580728A CA 580728 A CA580728 A CA 580728A CA 1327019 C CA1327019 C CA 1327019C
- Authority
- CA
- Canada
- Prior art keywords
- solution
- group
- washing
- lower alkyl
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000005406 washing Methods 0.000 title claims abstract description 24
- 210000000056 organ Anatomy 0.000 title claims abstract description 20
- -1 organogermanium compound Chemical class 0.000 claims abstract description 16
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 10
- 229910052751 metal Inorganic materials 0.000 claims abstract description 10
- 239000002184 metal Substances 0.000 claims abstract description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 9
- 125000003277 amino group Chemical group 0.000 claims abstract description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 6
- 239000011734 sodium Substances 0.000 claims abstract description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 4
- 150000001413 amino acids Chemical class 0.000 claims abstract description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 4
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 4
- 239000011591 potassium Substances 0.000 claims abstract description 4
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 4
- 102000016943 Muramidase Human genes 0.000 claims abstract 2
- 108010014251 Muramidase Proteins 0.000 claims abstract 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract 2
- 229960000274 lysozyme Drugs 0.000 claims abstract 2
- 235000010335 lysozyme Nutrition 0.000 claims abstract 2
- 239000004325 lysozyme Substances 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 62
- 239000000203 mixture Substances 0.000 claims description 18
- 239000008151 electrolyte solution Substances 0.000 claims description 9
- 210000002977 intracellular fluid Anatomy 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 4
- 150000002894 organic compounds Chemical class 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 abstract description 14
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 description 18
- 241000282472 Canis lupus familiaris Species 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 229940021013 electrolyte solution Drugs 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical group [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000000576 supplementary effect Effects 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- XRYJTKGEJGVBCC-UHFFFAOYSA-N 2-germylpropanoic acid Chemical compound CC([GeH3])C(O)=O XRYJTKGEJGVBCC-UHFFFAOYSA-N 0.000 description 1
- ZJUHNMADISSFJZ-UHFFFAOYSA-N 2-trichlorogermylpropanoic acid Chemical compound OC(=O)C(C)[Ge](Cl)(Cl)Cl ZJUHNMADISSFJZ-UHFFFAOYSA-N 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N 5-hydroxylysine Chemical group NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 102100027522 Baculoviral IAP repeat-containing protein 7 Human genes 0.000 description 1
- 101710177963 Baculoviral IAP repeat-containing protein 7 Proteins 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 238000010669 acid-base reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 230000007159 enucleation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 125000001145 hydrido group Chemical group *[H] 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 125000000082 organogermanium group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
- A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP273745/1987 | 1987-10-29 | ||
| JP62273745A JPH01117801A (ja) | 1987-10-29 | 1987-10-29 | 分離臓器洗浄保存液 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1327019C true CA1327019C (en) | 1994-02-15 |
Family
ID=17531980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000580728A Expired - Lifetime CA1327019C (en) | 1987-10-29 | 1988-10-20 | Solution for washing and storing separated organs |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4956272A (enExample) |
| JP (1) | JPH01117801A (enExample) |
| CA (1) | CA1327019C (enExample) |
| DE (1) | DE3836650C2 (enExample) |
| FR (1) | FR2622396B1 (enExample) |
| GB (1) | GB2211394B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01149723A (ja) * | 1987-12-07 | 1989-06-12 | Asai Gerumaniumu Kenkyusho:Kk | 骨芽細胞活性化剤 |
| AU635045B2 (en) * | 1989-07-20 | 1993-03-11 | Asai Germanium Research Institute Co., Ltd | Agent for preventing and treating opacity of lens |
| US5328821A (en) * | 1991-12-12 | 1994-07-12 | Robyn Fisher | Cold and cryo-preservation methods for human tissue slices |
| RU2025973C1 (ru) * | 1992-02-10 | 1995-01-09 | Научно-производственное предприятие "Биофарм" | Раствор для консервации живых органов |
| US5386046A (en) * | 1994-03-02 | 1995-01-31 | Viva America Marketing, Inc. | Method for the preparation of pure carboxyethyl germanium sesquioxide |
| US5919964A (en) * | 1994-03-02 | 1999-07-06 | Viva America Marketing, Inc. | Method for the preparation of pure carboxyethyl germanium sesquioxide |
| US5550266A (en) * | 1994-03-02 | 1996-08-27 | Arnold; Michael J. | Method for the preparation of pure carboxyethyl germanium sesquioxide |
| US5703259A (en) * | 1994-03-02 | 1997-12-30 | Viva America Marketing Inc | Method for the preparation of pure carboxyethyl germanium sesquioxide |
| WO2021127784A1 (en) * | 2019-12-24 | 2021-07-01 | Unity Health Toronto | Method and system for photoacoustic imaging of tissue and organ fibrosis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1793288B1 (de) * | 1968-03-29 | 1971-05-27 | Daiichi Yakuhin Sangyo Kk | Verfahren zur Herstellung von Organogermaniumoxiden |
| BE834794A (fr) * | 1975-10-23 | 1976-02-16 | Acide 3-trihydroxygermano-propionique | |
| US4271084A (en) * | 1978-03-01 | 1981-06-02 | Ryuichi Sato | Germanium-containing organic polymer and the process for the production of the same |
| FR2548187B1 (fr) * | 1983-07-01 | 1988-07-15 | Asai Germanium Res Inst | Composes d'organo-germanium et leurs utilisations therapeutiques en tant qu'inhibiteurs des enzymes qui degradent les peptides opioides |
| JPS6016924A (ja) * | 1983-07-11 | 1985-01-28 | Asai Gerumaniumu Kenkyusho:Kk | 抗腫瘍剤 |
| JPS63107920A (ja) * | 1986-06-18 | 1988-05-12 | Asai Gerumaniumu Kenkyusho:Kk | 骨芽細胞活性化剤 |
-
1987
- 1987-10-29 JP JP62273745A patent/JPH01117801A/ja active Granted
-
1988
- 1988-10-20 CA CA000580728A patent/CA1327019C/en not_active Expired - Lifetime
- 1988-10-24 US US07/261,628 patent/US4956272A/en not_active Expired - Lifetime
- 1988-10-27 DE DE3836650A patent/DE3836650C2/de not_active Expired - Fee Related
- 1988-10-27 FR FR8814057A patent/FR2622396B1/fr not_active Expired - Fee Related
- 1988-10-27 GB GB8825169A patent/GB2211394B/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US4956272A (en) | 1990-09-11 |
| JPH05361B2 (enExample) | 1993-01-05 |
| FR2622396A1 (fr) | 1989-05-05 |
| GB2211394A (en) | 1989-07-05 |
| FR2622396B1 (fr) | 1993-03-19 |
| GB2211394B (en) | 1991-10-23 |
| DE3836650C2 (de) | 1994-09-15 |
| JPH01117801A (ja) | 1989-05-10 |
| DE3836650A1 (de) | 1989-05-11 |
| GB8825169D0 (en) | 1988-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1327019C (en) | Solution for washing and storing separated organs | |
| Wood et al. | The physiology of waterborne silver toxicity in freshwater rainbow trout (Oncorhynchus mykiss) 1. The effects of ionic Ag+ | |
| Massmann | Toxicological investigations on dimethylformamide | |
| US5506345A (en) | Metal complexes for hypoxic cells | |
| KR890004609A (ko) | 살균제 | |
| JPH02503910A (ja) | 置換された環状錯形成剤、錯体及び錯塩、その製法及びこれを含有する製薬学的製剤 | |
| BOUDJEMA et al. | Effect of oxidized and reduced glutathione in liver preservation | |
| JPH0248655A (ja) | 新規ｄｉｒ化合物を含有する写真材料 | |
| DE69430473T2 (de) | Verwendung von in 4-(oder 5-) substituierten 2-mercaptoimidazolderivat als antioxidantien, verfahren zu ihrer herstellung und ihre anwendung in der pharmazie, in der kosmetik und in lebensmitteln | |
| Sunderman et al. | Effects of nickel chloride and diethyldithiocarbamate on metallothionein in rat liver and kidney | |
| PL182414B1 (pl) | Kompozycja do zabezpieczania zywej tkanki ssaka przed uszkodzeniem PL | |
| Li et al. | Sex differences in ferric nitrilotriacetate-induced lipid peroxidation and nephrotoxicity in mice | |
| US4919917A (en) | Agent for reducing nephrotoxicity caused by cyclosporin administration | |
| Hongxia et al. | Toxicity andaccumulation of tributyltin chloride on tilapia | |
| Chollet et al. | Fungicidal activity of a series of 1‐substituted‐1‐aryl‐2‐triazol‐1‐yl‐ethanols | |
| Ceconi et al. | Lipid peroxidation during myocardial reperfusion | |
| CA1314210C (en) | Agent for improving reduced functions of organs caused by inhibited blood circulation | |
| Belakhov et al. | Organosilicon Derivatives of β-D-Ribofuranoside: Synthesis, Pharmacological Study, and Insecticidal Activity | |
| Sekido et al. | Molecular Structure and Extraction Behavior of Silver (I)-13, 14-Benzo-1, 4, 8, 11-tetrathiacyclopentadec-l3-ene Picrate Complex | |
| Singh et al. | Structural factors in the in vivo chelate mobilization of aged cadmium deposits. | |
| JP2856385B2 (ja) | 新規ピペコリン酸誘導体及びその製造法 | |
| Louloudi et al. | Solution versus solid state conformation of Group 12 metal complexes of active aldehyde derivatives of thiamine | |
| Gower et al. | The importance of oxygen free radicals, iron and calcium in renal ischaemia | |
| Velazquez-Garcia et al. | Crystal structure of tris [hexakis (imidazole) cobalt (II)] bis (benzene-1, 3, 5-tricarboxylate) | |
| FR2461704A1 (fr) | Compose basique de styrene et procede pour sa preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |
Effective date: 20110215 |